GlassScriptPhysician profile
Marianna Griffith Law
NPI 1457542649
$2,839.19
in general payments reported to CMS, 2019-2025
45 companies · $748 in 2025
The $748 reported for 2025 was more than what 81% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $193 · 2021: $225 · 2022: $141 · 2023: $371 · 2024: $604 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $439.54 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Mayne Pharma Commercial LLC | $220.77 | 2021-2025 | |
| Amgen INC. | $214.07 | 2019-2024 | Evenity, Otezla, Prolia |
| Astellas Pharma US INC | $205.02 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $183.04 | 2025 | Myfembree, Gemtesa |
| Abbott Laboratories | $149.16 | 2021-2025 | Eterna, Freestyle Libre 3, Proclaim |
| Lilly USA, LLC | $118.37 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $111.90 | 2019-2022 | |
| Hologic Sales and Service, LLC | $79.35 | 2019-2024 | Myosure Tissue Removal Device, Acessa Provu System, Omni Hysteroscope |
| Bayer Healthcare Pharmaceuticals INC. | $71.18 | 2023-2025 | |
| Daiichi Sankyo INC. | $67.57 | 2019-2024 | Injectafer |
| Exeltis, USA INC. | $66.61 | 2023-2025 | Slynd |
| Merck Sharp & Dohme LLC | $62.06 | 2020-2024 | Gardasil 9, Gardasil, Capvaxive |
| Evofem Biosciences, INC. | $61.55 | 2022-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $59.68 | 2023-2025 | Nexplanon |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianna Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.